Asset Dedication LLC’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Asset Dedication LLC’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.4K	Hold	593	–	–	﹤0.01%	639
2025 Q4	$19.5K	Hold	593	–	–	﹤0.01%	669
2025 Q3	$16.9K	Hold	593	–	–	﹤0.01%	716
2025 Q2	$15.2K	Hold	593	–	–	﹤0.01%	749
2025 Q1	$16.3K	Hold	593	–	–	﹤0.01%	685
2024 Q4	$16K	Hold	593	–	–	﹤0.01%	695
2024 Q3	$17.1K	Hold	593	–	–	﹤0.01%	717
2024 Q2	$16.2K	Hold	593	–	–	﹤0.01%	725
2024 Q1	$17K	Hold	593	–	–	﹤0.01%	612
2023 Q4	$16K	Hold	593	–	–	﹤0.01%	614
2023 Q3	$15K	Hold	593	–	–	﹤0.01%	614
2023 Q2	$16K	Hold	593	–	–	﹤0.01%	599
2023 Q1	$15K	Hold	593	–	–	﹤0.01%	600
2022 Q4	$16K	Hold	593	–	–	﹤0.01%	585
2022 Q3	$14K	Hold	593	–	–	﹤0.01%	572
2022 Q2	$16K	Hold	593	–	–	﹤0.01%	309
2022 Q1	$16K	Hold	593	–	–	﹤0.01%	592
2021 Q4	$16K	Hold	593	–	–	﹤0.01%	582
2021 Q3	$15K	Buy	593 +193	+48%	+$5.07K	﹤0.01%	619
2021 Q2	$10K	Hold	400	–	–	﹤0.01%	619
2021 Q1	$10K	Hold	400	–	–	﹤0.01%	503
2020 Q4	$10K	Hold	400	–	–	﹤0.01%	556
2020 Q3	$10K	Hold	400	–	–	﹤0.01%	525
2020 Q2	$9K	Buy	+400	New	+$8.86K	﹤0.01%	468

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Asset Dedication LLC's FTXH Position: Q1 2026 in Review

Asset Dedication LLC held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q1 2026 at 593 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Asset Dedication LLC first reported a position in FTXH in Q2 2020 and has held it in 24 quarters since. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

Asset Dedication LLC held 593 shares of First Trust Nasdaq Pharmaceuticals ETF worth $20.4K as of Q1 2026.
Asset Dedication LLC left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q1 2026.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Asset Dedication LLC's portfolio in Q1 2026, its #639 holding.
Asset Dedication LLC first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2020 and has held it in 24 quarters since.
32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.